Bio-Europe 2020

BCI Pharma will discuss with pharmas and investors on their promising research projects.

BCI Pharma is delighted to communicate that the company has received a grant from the DG06 (Belgium) to financially support its second research programm.

BCI Pharma is proud to announce that Didier Malherbe accepted his nomination as board chairman. Didier will reinforce BCI structure, participate in BCI development phase and connect to more pharma experts.